Butongkay, Rasmin .
HRN: 28-77-90 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/08/2026
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
04/08/2026
04/08/2026
IVT
1g
SD PTOR
Stat CS
Checking Initial Appropriateness
Indication: Prophylaxis Type of Infection: Prophylaxis Compliance to guidelines: Compliant To Guidelines